Washington SB 5401: Addressing prescription drug cost transparency.

Status: Due to Senate committee reorganization, referred to Health & Long Term Care. (as of 2018-01-08)

State: Washington · Session: 2017-2018 · Bill: SB 5401

Subjects: INSURANCE, FINANCIAL MANAGEMENT, OFFICE, DRUGS

Sponsors: Rivers, Carlyle, Cleveland, Conway, Hasegawa, Keiser, Kuderer, Miloscia, Pedersen, Rolfes, Saldaña, Wellman

View Washington SB 5401 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.